Tuesday, May 31, 2016

Defense Authorization Act

Support Amendment #4369 to the National Defense Authorization Act (NDAA)

Senators Casey and Toomey,

As your constituent and as an MS activist, I urge you to oppose Sections 756 and 898 of FY 2017 National Defense Authorization Act (NDAA, S. 2943), which would unnecessarily burden medical research with bureaucratic red tape.

Please support amendment #4369 led by Senators Durbin and Senator Cochran during floor consideration of S. 2943: to strike this dangerous language from the bill and support continued investments in the medical research programs at the Department of Defense (DoD).

Section 756 would require a determination by the Secretary for every medical research and development project funded by DoD, a burden that does not apply to other DoD-funded research and that would jeopardize funding for activities with broader relevance to the U.S. military (including the health and well-being of military families and veterans, and the efficiency of the military health care system). Please support amendment #4369 to strike Section 756.

Section 898 places unnecessary acquisition compliance and auditing requirements on medical research programs that already serve taxpayers well. It would subject researchers to a level of scrutiny not required for any other federal government research grants (such as those funded by the National Institutes of Health), a level currently reserved for complex, multi-million dollar acquisitions systems -- needlessly delaying research for months or even years. Please support amendment #4369 to strike Section 898.

Senators Durbin and Cochran are leading a bipartisan group of senators from across the country to remove these provisions from the bill so that this life-saving medical research can continue. Please support amendment #4369! It is critical to protect the MSRP so we can move closer to a world free of MS!


Sincerely,

No comments:

Post a Comment